Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513)
The special instructions and independent opinions of the independent directors on the company’s external guarantees are in accordance with the relevant provisions of the guidelines for the supervision of listed companies No. 8 – regulatory requirements for capital transactions and external guarantees of Listed Companies [2022] No. 26 and the articles of association jointly issued by the CSRC, the Ministry of public security, the SASAC and the China Banking and Insurance Regulatory Commission, We have inspected the external guarantee of Chengdu Easton Bio Pharmaceuticals Co.Ltd(688513) (hereinafter referred to as “the company”), and after careful inspection, we express the following independent opinions:
1、 Description of external guarantee:
After inspection, as of December 31, 2021, the balance of external guarantee of the company was 0 yuan, and there was no external guarantee for the company and its subsidiaries in 2021.
2、 Independent opinions on external guarantee:
As of December 31, 2021, the company has strictly complied with the relevant provisions of relevant laws and regulations on guarantee matters, and there is no damage to the interests of the company and its shareholders, especially minority shareholders.
Independent directors: Jin Li, Fang Fang, Shang Shu March 28, 2022
